BioMérieux

TTI Success Insights Names Patrick Lectone as International Brand Ambassador of the Year

Retrieved on: 
Wednesday, March 1, 2023
Airbus, Global distribution system, Channel, Organization, Bombardier, Brand ambassador, BioMérieux, France, LVMH, TTI, Film industry

SCOTTSDALE, Ariz., March 1, 2023 /PRNewswire-PRWeb/ -- TTI Success Insights (TTI SI), a leading resource for research-based assessments and talent management solutions, announced Patrick Lectone of TTI SI France as the International Brand Ambassador of the Year.

Key Points: 
  • SCOTTSDALE, Ariz., March 1, 2023 /PRNewswire-PRWeb/ -- TTI Success Insights (TTI SI), a leading resource for research-based assessments and talent management solutions, announced Patrick Lectone of TTI SI France as the International Brand Ambassador of the Year.
  • The Brand Ambassador of the Year award applauds superior engagement with TTI SI's brand; it goes to someone who has gone above and beyond to promote recognition in the industry.
  • His diligent work promotes and integrates TTI Success Insights assessments in various organizations worldwide to help improve people's lives and working conditions.
  • TTI Success Insights Award winners were honored with special recognition during a virtual award ceremony on January 26th, 2023.

Renal Biomarkers Technologies and Global Markets Report 2022-2027: Patent Reviews, Clinical Trial Analysis, Competitive Landscape, Techniques - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 25, 2023
Health, Biotechnology, Biomarker, Acute kidney injury, Kidney, AKI, Thermo Fisher Scientific, Hospital, CKD, Patient, Incidence, Disease, Diabetes, Research, BioMérieux, Intelligence, Hypertension, Death, Chronic kidney disease, COVID, Prevalence, COVID-19, R, Retail, Pharmaceutical industry, Medical imaging

The "Renal Biomarkers: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Renal Biomarkers: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.
  • This report incorporates an in-depth analysis of the renal biomarker market, including market estimations and trends through 2021.
  • The report presents a market analysis and estimates the CAGR for renal biomarkers.
  • The scope of the report extends only to renal biomarker consumables and not devices used to study renal biomarkers.

United States Molecular Diagnostics Market Analysis Report 2022: A $12.5 Billion Market by 2027 - Industry Trends, Growth, Insights, Impact of COVID-19, Company Analysis - ResearchAndMarkets.com

Retrieved on: 
Friday, November 25, 2022
Health, Biotechnology, COVID-19, Diagnosis, BioMérieux, Laboratory, Infection, Cell, Gene, United States national laboratories, Abbott Laboratories, Myriad Genetics, Roche Diagnostics, Projection, Patient, POC, Proteome, Government, Gen-Probe, NHS England, Ageing, Cancer, Genome, Protein, FISH, RNA transfection, PCR, Abbott, Power-on self-test, ID, Prognosis, Genetic testing, Death, CE, ISH, Research, Real-time polymerase chain reaction, Danaher Corporation, Cobas, Coronavirus, NHS, England, Investment, Pharmaceutical industry, Medical device, Medical imaging, Growth

The "United States Molecular Diagnostics Market, Size, Share, Forecast 2022-2027, Industry Trends, Growth, Insights, Impact of COVID-19, Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "United States Molecular Diagnostics Market, Size, Share, Forecast 2022-2027, Industry Trends, Growth, Insights, Impact of COVID-19, Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • Molecular diagnostics has developed as a superior methodology in the United States over the previous decade, achieving the goal of speedier disease diagnosis with fewer complexities.
  • The COVID-19 outbreak is expected to boost the growth of the Molecular Diagnostics Market in the United States.
  • In the United States molecular diagnostics market in 2021, the infectious illness category held the most significant market share.

Mexico In-Vitro Diagnostics Market Report 2022: Increase in Adoption of Self-Administration Practices Provides Boost to Sector - ResearchAndMarkets.com

Retrieved on: 
Friday, October 21, 2022
Pharmaceutical, Health, Medical Devices, Thermo Fisher Scientific, Health care, Prevalence, Growth, Population, Abbott Laboratories, Infection, CAGR, Patient, Danaher Corporation, End user, WHO, BioMérieux, Sysmex Corporation, Company, Disability, IVD, Marketing, Industry, Becton, Dickinson and Company headquarters, Health, Obesity, US, Application, Disease, Face, Ageing, Siemens Healthineers, Diabetes, Usability, Conditional sentence, Lists of television programs, Medical device

Rising geriatric population and subsequent growth in the prevalence of chronic and infectious diseases is expected to boost the growth of the Mexico in-vitro diagnostics market during the forecast period.

Key Points: 
  • Rising geriatric population and subsequent growth in the prevalence of chronic and infectious diseases is expected to boost the growth of the Mexico in-vitro diagnostics market during the forecast period.
  • It profiles key players in the Mexico in-vitro diagnostics market based on the following parameters, such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Mexico in-vitro diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Mexico in-vitro diagnostics market.

The Worldwide Infectious Disease In Vitro Diagnostics Industry is Expected to Reach $56.6 Billion by 2030 - ResearchAndMarkets.com

Retrieved on: 
Friday, October 7, 2022
Infectious Diseases, Biotechnology, Health Technology, Health, Adoption, ICU, Technology, Prevalence, Diagnosis, Infection, Severe acute respiratory syndrome coronavirus 2, CAGR, POC, Patient, BioMérieux, HIV, Industry, Tuberculosis, Awareness, Hoffmann-La Roche, MDR, HPV, COVID-19, USD, BD, Medical device, Pharmaceutical industry, Application

The global infectious disease in vitro diagnostics market size is expected to reach USD 56.60 billion by 2030, registering a CAGR of -7.4% from 2022 to 2030, according to this report.

Key Points: 
  • The global infectious disease in vitro diagnostics market size is expected to reach USD 56.60 billion by 2030, registering a CAGR of -7.4% from 2022 to 2030, according to this report.
  • The rising prevalence of infectious diseases, such as tuberculosis & COVID-19, and technological advancements are projected to drive the product demand in the coming years.
  • The rising prevalence of multi-drug resistant infections is enhancing the early diagnosis of infectious diseases.
  • Competitive rivalry is estimated to increase during the forecast period owing to the expected launch of novel biomarker kits.

Global Biotechnology Market (2022-2027) by Technology, Application, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis - ResearchAndMarkets.com

Retrieved on: 
Monday, July 25, 2022
Health, Biotechnology, Abbott, SWOT, Investment, Biogen, COVID-19, Market development, Chromatography, Industry, Food, Nature, Risk, Agilent Technologies, Amgen, USD, Ansoff Matrix, Geography, Technology, CAGR, Industrial process imaging, AstraZeneca, Emotion, Competitive analysis, Impact, Growth, DNA sequencing, Pharmaceutical industry, Risk management, Retail, Fine chemical, Application, Nanobiotechnology, Health, Fermentation, BioMérieux

The "Global Biotechnology Market (2022-2027) by Technology, Application, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Biotechnology Market (2022-2027) by Technology, Application, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
  • Market dynamics are forces that impact the prices and behaviors of the Global Biotechnology Market stakeholders.
  • The report presents a detailed Ansoff matrix analysis for the Global Biotechnology Market.
  • The report analyses the Global Biotechnology Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Metabolon Appoints Tom Houseman as Vice President of Operations

Retrieved on: 
Monday, July 25, 2022
ISO, Metabolomics, Twitter, CEO, Environmental studies, NextGen Healthcare, Research, Biomarker, Houseman, Solution, Compliance, Lipidomics, Health, Diet, Multimedia, Drug development, Publication, Technology, Genetic variation, Patient, LinkedIn, Precision medicine, Efficiency, East Stroudsburg University of Pennsylvania, Growth, BioMérieux, Management, Fine chemical, Pharmaceutical industry, Metabolon, Biology, Hospira, Science, Operation

MORRISVILLE, N.C., July 25, 2022 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions that advance drug development and precision medicine, today announced that Tom Houseman has been appointed Vice President of Operations. Joining the company's leadership team, Houseman will be instrumental in accelerating and enabling process efficiency and capability across Metabolon testing and operations, as well as Metabolon facilities.

Key Points: 
  • An accomplished leader in laboratory innovations and diagnostics, Houseman will enable process efficiency and capability across Metabolon testing and operations
    MORRISVILLE, N.C., July 25, 2022 /PRNewswire/ -- Metabolon , Inc., the global leader in providing metabolomics solutions that advance drug development and precision medicine, today announced that Tom Houseman has been appointed Vice President of Operations.
  • Joining the company's leadership team, Houseman will be instrumental in accelerating and enabling process efficiency and capability across Metabolon testing and operations, as well as Metabolon facilities.
  • Previously, Houseman served as Vice President of Operations at bioMerieux, Inc, where he led all aspects of manufacturing and supply for bioMerieux's 500-person Durham production site.
  • "We are delighted to welcome Tom to the Metabolon team," said Rohan (Ro) Hastie, President & CEO of Metabolon.

Global Digital Genome Market Research Report 2022-2027 - Leading Players are bioMerieux, Agilent Technologies, Inscripta, GE Healthcare, and Invitae - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 12, 2022
Software, Technology, Genetics, Health, Technology, COVID-19, Molecular epidemiology, Health, Vaccine, Pan American Health Organization, Severe acute respiratory syndrome coronavirus 2, Sophia, Genomics, PAHO, VOC, Patient, Artificiality, Laboratory, Omicron, Genetics, AI, Artificial intelligence, GENETICS, Collection, GE Healthcare, CAGR, Research, Agilent Technologies, Adoption, Workforce, Drug development, Medicine, Sophia Genetics, BioMérieux, Growth

The global digital genome market is expected to register a CAGR of more than 10% over the forecast period, 2022-2027.

Key Points: 
  • The global digital genome market is expected to register a CAGR of more than 10% over the forecast period, 2022-2027.
  • The COVID-19 pandemic is an unprecedented health concern and has significantly impacted the digital genome market worldwide.
  • The digital genome market is competitive with the presence of several global and international market players.
  • Some of the key players in the market are bioMerieux, Agilent Technologies, Inscripta, Inc., GE Healthcare and Invitae Corporation.

Global Microbiology Diagnostic Devices and Equipment Markets Report 2022: Breakdown by Incubators, Gram Stainers, Bacterial Colony Counters, Petri Dish Fillers, & Automated Culture Systems - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 23, 2022
Biotechnology, Health, Medical Devices, Microbiology, COVID-19, Bruker, Demography, Thermo Fisher Scientific, Abbott Laboratories, Forecasting, Company, Incubator, Hyco International Inc, Growth, Infection, Danaher, Merck Group, Geography, Becton, Dickinson and Company headquarters, Medical device, Retail, BioMérieux

The "Global Microbiology Diagnostic Devices And Equipment Market Report 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Microbiology Diagnostic Devices And Equipment Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
  • Microbiology Diagnostic Devices And Equipment Global Market Report 2022 covers this critical market and the impact on it from the COVID-19 virus.
  • The Microbiology Diagnostic Devices And Equipment Market Global report answers all these questions and many more.
  • Global Microbiology Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Research Report 2022 - ResearchAndMarkets.com

Retrieved on: 
Friday, June 3, 2022
Medical Devices, Infectious Diseases, Hospitals, Health, Medical Supplies, Tick-borne disease, Biomarker, LFIA, Company, Food, Infection, Point-of-care testing, POCT, Siemens, A*STAR, Animal, Hologic, Disease, Becton, Dickinson and Company headquarters, University, Blood, Immunoglobulin G, Serum, Method, Immunoglobulin A, Hospital, Coronavirus, Immunoglobulin M, COVID-19, Harvard University, Thermo Fisher Scientific, Antibody, QIAGEN, Toxicology, Severe acute respiratory syndrome coronavirus 2, BioMérieux, SRL Diagnostics, Abbott Laboratories, Pregnancy, Gertrude Pocte Geddes Willis, Asia-Pacific, POC, Danaher Corporation, Application, Fertility, Bio-Rad Laboratories, Ol-molog, Medical device, Oil, Pharmaceutical industry, Vaccine

The "Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
  • The lateral flow immunoassay (LFIA) based rapid test market consists of sales of devices and equipment used to run lateral flow immunoassays (LFIA) based rapid test and related services by companies that develop lateral flow immunoassays (LFIA) based rapid test equipment.
  • Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
    6.2.
  • Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
    6.3.